Augmented Reality Guided Biopsy for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to guide biopsies, which involve taking a small tissue sample to check for cancer. It employs augmented reality, a technology that overlays digital information on the real world, to assist doctors during the biopsy. Participants are divided into two groups: one using this new technology and another using standard methods like CT scans and ultrasounds. Suitable candidates for this trial are adults needing a soft-tissue biopsy, particularly those with lesions between 1 and 8 centimeters deep. As an unphased trial, this study provides patients the chance to experience cutting-edge technology that could enhance biopsy accuracy and outcomes.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the XR90 Augmented Reality imaging and guidance platform is safe for percutaneous soft tissue biopsy?
Research shows that the XR90 augmented reality (AR) guidance system is safe and effective for procedures like biopsies. Studies have found that it reduces radiation exposure and decreases the number of CT scans needed during bone biopsies, without increasing side effects. Patients generally tolerate the system well.
Tests in both lab and real-world settings have confirmed its safety and effectiveness. While this trial aims to explore these benefits further, previous research offers a reassuring background for considering the XR90 system a safe choice for guided biopsies.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the use of augmented reality (AR) in guiding biopsies for cancer. Unlike standard biopsy procedures that rely solely on CT and ultrasound for needle guidance, the experimental approach uses the XR90 guidance system, which integrates augmented reality to enhance precision. This innovative method could potentially improve accuracy and reduce the risks associated with biopsies, making it a promising advancement in cancer diagnostics.
What evidence suggests that the XR90 Augmented Reality Guided Biopsy is effective for cancer?
This trial will compare augmented reality (AR) in biopsy procedures with standard care methods. Research has shown that AR can enhance the accuracy of biopsy procedures. Studies have found that AR systems help doctors target the right tissues, reducing mistakes. One AR system demonstrated high precision and speed, making the procedure smoother. These systems also allow doctors to see a 3D image of the needle and tumor, ensuring precise needle insertion. Overall, AR technology in biopsies appears promising for increasing precision and safety. Participants in this trial may be assigned to the experimental group using the XR90 AR guidance system or to the standard care group using traditional CT and ultrasound guidance.34567
Are You a Good Fit for This Trial?
This trial is for individuals who require a biopsy of soft tissue due to conditions like liver or kidney cancer. Participants should be suitable candidates for ultrasound-guided biopsies and willing to try an augmented reality guidance system.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intraprocedural
Participants undergo percutaneous biopsy procedures using either standard of care guidance or the XR90 guidance system
Follow-up
Participants are monitored for safety and effectiveness after the procedure
What Are the Treatments Tested in This Trial?
Interventions
- Augmented Reality Guided Biopsy
Trial Overview
The study tests the XR90 Augmented Reality imaging and guidance platform against standard ultrasound-guided biopsy techniques in patients undergoing soft tissue biopsies, aiming to assess safety and procedural benefits.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants randomly assigned to this arm will undergo percutaneous biopsy procedures using the assistance of XR90 guidance system in adjunct to standard of care guidance.
Participants randomly assigned to this arm will undergo percutaneous biopsy with standard of care CT and ultrasound needle guidance only.
Find a Clinic Near You
Who Is Running the Clinical Trial?
MediView XR, Inc.
Lead Sponsor
Citations
Augmented Reality Real-Time Guidance for MRI-Guided ...
The purpose of this research is to evaluate the safety and feasibility of using a needle guidance system (LUMENA) create by CLEAR GUIDE MEDICAL ...
An augmented reality-guided biopsy system using a high- ...
In this study, we developed an augmented reality (AR) system to improve biopsy procedures and increase targeting accuracy. Our AR-guided biopsy system uses a ...
Navigate biopsy with ultrasound under augmented reality ...
This paper introduces an AR-based ultrasound biopsy navigation system characterized by high navigation accuracy and minimal latency.
Augmented Reality Guided Biopsy for Cancer
This trial is for individuals who require a biopsy of soft tissue due to conditions like liver or kidney cancer. Participants should be suitable candidates for ...
Augmented Reality Guided Needle Biopsy of Soft Tissue
This system is designed to track and visualize the needle and tumor in three-dimensional space using an electromagnetic tracking system.
Clinical Evaluation of an Augmented Reality ...
This multicenter prospective randomized control trial is designed to compare the efficacy and utility of the XR90 guidance platform used adjunct to standard of ...
Bone biopsies guided by augmented reality: a pilot study
This AR navigation system is safe, feasible, and effective; it can decrease radiation exposure and number of CT passes during bone biopsies without increasing ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.